Acceleron Pharma

Acceleron is a privately held biopharmaceutical company committed to discover, develop, manufacture and commercialize novel biotherapeutics that modulate the growth of red blood cells, bone, muscle, fat and the vasculature to treat musculoskeletal, metabolic and cancer-related diseases.

ACE-083  The lead product candidate in the neuromuscular therapeutic programme. Current ACE-083 Studies: Study of ACE-083 in Patients with FSHD – Active, not recruiting Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients with FSHD and CMT Disease Types 1 and X – Recruiting Study of ACE-083 in Patients with Charcot-Marie Tooth Disease – Recruiting